Clinical Trials | April 22, 2026
Moderna launches late-stage trial of mRNA bird flu vaccine
The start of our Phase 3 trial for an H5 influenza vaccine marks a significant milestone
The start of our Phase 3 trial for an H5 influenza vaccine marks a significant milestone
The approval, following a positive recommendation from the European Medicines Agency’s CHMP, makes the vaccine valid across all 27 EU member states
The company said it is supporting the ongoing investigation and reiterated its commitment to patient safety.
The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence
Consensus calls for nationwide adoption of potassium-enriched salt to reduce cardiovascular disease risk
This combination works to break down rough patches, improve moisture retention, and enhance overall skin texture
Visit underscores push for self-reliance in essential medical consumables and India’s ambition to become a global medtech manufacturing hub
The perinatology CME at Navi Mumbai brought together more than 100 obstetricians, pediatricians, and neonatologists
Exclusive distribution pact with Amcor broadens access to Parafilm M sealing solutions for laboratories, horticulture and industrial users
Scientists at the forum warned of an increasingly volatile health landscape
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
